Avidity Partners Management LP Verastem, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$1.11 - $1.68 $4.9 Million - $7.42 Million
-4,414,991 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.69 - $4.2 $2.75 Million - $6.82 Million
1,624,293 Added 58.2%
4,414,991 $7.59 Million
Q1 2020

Jun 17, 2020
BUY
$1.26 - $3.38 $3.52 Million - $9.43 Million
2,790,698 New
2,790,698 $7.37 Million

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.25B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email